ACE gene alleles may indicate benefit of -blockers in HF survival

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1290, 2001-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE inhibitors: survival benefit over calcium channel antagonists

By  

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

The development of rash during erlotinib therapy may indicate a greater likelihood of clinical benefit

By  

Inpharma, Vol. 1, Iss. 1603, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation

By  

Current Pharmaceutical Design, Vol. 18, Iss. 28, 2012-09 ,pp. : 4385-4413

Bentham Science Publishers

Access to resources Recommend Favorite

Aspirin may offer less survival benefit in patients with diabetes after acute coronary syndromes than in those without diabetes

By  

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

β-blockers underprescribed, inadequately dosed in AMI, HF

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite